Defeng Qi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 6
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Weidong Ji (11 shared papers)Haiqing Zhang (3 shared papers)Xiaoling Ying (4 shared papers)Shuibin Lin (3 shared papers)Biao Que (5 shared papers)Min Wang (2 shared papers)Huan Jin (2 shared papers)Yinghui Chao (2 shared papers)
- Journals
- Cancer Cell International (2 papers)PLoS ONE (2 papers)Frontiers in Pharmacology (1 paper)Oncogene (1 paper)The Prostate (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Defeng Qi
29 papers receiving 849 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 361
- Molecular Biology 600
- Renewable Energy, Sustainability and the Environment 80
- Pulmonary and Respiratory Medicine 137
- Pediatrics, Perinatology and Child Health 57
Countries citing papers authored by Defeng Qi
This map shows the geographic impact of Defeng Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defeng Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defeng Qi more than expected).
Fields of papers citing papers by Defeng Qi
This network shows the impact of papers produced by Defeng Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defeng Qi. The network helps show where Defeng Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Defeng Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 163 | |
| 2 | 2019 | 152 | |
| 3 | 2021 | 137 | |
| 4 | 2016 | 56 | |
| 5 | 2012 | 54 | |
| 6 | 2016 | 46 | |
| 7 | 2023 | 39 | |
| 8 | 2024 | 31 | |
| 9 | 2024 | 24 | |
| 10 | 2011 | 19 | |
| 11 | 2019 | 18 | |
| 12 | 2015 | 17 | |
| 13 | The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis. | 2015 | 16 |
| 14 | 2018 | 14 | |
| 15 | 2011 | 12 | |
| 16 | 2021 | 8 | |
| 17 | 2014 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2011 | 5 | |
| 20 | 2023 | 5 |
About Defeng Qi
Defeng Qi is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Renewable Energy, Sustainability and the Environment, having authored 29 papers that have together received 852 indexed citations. Recurring topics across this work include Electrocatalysts for Energy Conversion (7 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers), Advanced battery technologies research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers), Catalytic Processes in Materials Science (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (361 citations), Molecular Biology (600 citations), Renewable Energy, Sustainability and the Environment (80 citations), Pulmonary and Respiratory Medicine (137 citations) and Pediatrics, Perinatology and Child Health (57 citations). Defeng Qi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weidong Ji, Haiqing Zhang, Xiaoling Ying, Shuibin Lin, Biao Que, Min Wang, Huan Jin, Yinghui Chao, Jialin Su and Wenjuan Zhang. Their work appears in journals such as Cancer Cell International, PLoS ONE, Frontiers in Pharmacology, Oncogene and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.